F.A.Q.

For pre-seed/seed/start-up companies:

• Serious and modern scientific research, carried out by famous scientists having a proven track record
• Opportunity of Protecting Intellectual Property
• Viability proofs of the proposed concept of the future product or technology (prototype, laboratory sample or, for instance, pre-clinical testing for projects involving medicinal drugs development)
• The expected product must secure considerable competitive advantages (commercial benefit)
• The amount of the required investments shall be rational and relevant to the solved task

For sales/growth companies:

All the requirements listed above for pre-seed/seed/start-up companies as well as:

• Legally protected intellectual property
• The prototype sample of the technology or product, developed within the project implementation (e.g., Phase 1 or 2 of clinical testing for medicinal products) and / or first sales
• Partially or completely formed project managers team will be an advantage
• Investments on the part of the qualified business angel will be an advantage

For expansion/liquidity companies:

• Qualified business team
• Prospectively innovative product with principally new, technical characteristics, and considerable competitive advantages
• Exponential growth forecasts with potential sales volume from USD 50 mln. on the prospective markets
• Legally pure business structure
• A strong, legal, intellectual property protection

The choice of Biotechnology and Fine Chemistry, as the areas of priority, is conditioned by the following:

• Priorities of the Russian Federation on the development of these areas within economy transition to innovative development;

• The historically strong position of Russia in biological and chemical science (the scientific-focussed schools, having advanced ideas, originated and developed in Russia);

• A high need for innovative products on the world market;

• An interest of core business, including in Russia, of innovative companies (projects, technologies, solutions);

• BCP Management Team has key competences in these spheres and is a unique composition of venture capital people, businessmen and scientists, having the required experience and knowledge.